Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    51,057.38
    -607.28 (-1.18%)
     
  • CMC Crypto 200

    1,327.83
    -68.71 (-4.92%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

ZoomInfo (ZI) Launches Privacy Clusters to Aid Data Privacy

ZoomInfo Technologies ZI recently introduced Privacy Clusters as a part of its premium Streaming Intent offering. It enables organizations to build data-compliant go-to-market strategies by producing business intent signals without using Cookies or Internet Protocol (IP) addresses.

The new solution enhances data privacy by delivering 100% Cookies-free tracking of company-level purchasing intent signals which will help companies target prospective customers in a timely manner. It maintains the anonymous status of individual customers to respect their privacy.

Moreover, it is compliant with all privacy legislations, such as the General Data Protection Regulation and the California Consumer Privacy Act, which gives its customers compliance assurance and hold over their own data.

Strong Product Portfolio Drives Growth

Notably, ZoomInfo’s shares have surged 35.6% year to date against the Zacks Computer - Integrated Systems industry’s decline of 3.8%.

ZoomInfo Technologies Inc. Price, Consensus and EPS Surprise

ZoomInfo Technologies Inc. Price, Consensus and EPS Surprise
ZoomInfo Technologies Inc. Price, Consensus and EPS Surprise

ZoomInfo Technologies Inc. price-consensus-eps-surprise-chart | ZoomInfo Technologies Inc. Quote

ADVERTISEMENT

 

This outperformance is primarily driven by the growing traction of the company’s go-to-market intelligence platform due to elevated consumer demand for data and insights. The company also benefits from its resilient subscription-based model amid the coronavirus outbreak.

Moreover, ZoomInfo’s top line in the third quarter of fiscal 2020 was aided by solid demand for its FormComplete, intent and InboxAI product with an increase in adoption of 33%, 67% and 40%, respectively.

Further, the company launched ZoomInfo Engage, a sales engagement platform, which enhances workplace optimization by providing an automated sales dialer with built-in email automation and technology. The new platform is expected to drive incremental growth and boost the company’s customer base.

ZoomInfo also introduced several enhancements to its platform such as a real-time intelligence feed, mobile experience improvements to Quick Search, and redesigns of contact profile alerts and the homepage. The company anticipates these innovations to fuel user engagement on its platform.

Notably, the company ended the third quarter with more than 720 customers, with $100K or greater in annual contract value, compared to 650 customers in the second quarter.

Moreover, the company recently acquired Clickagy, an AI-powered buyer intent signals provider and EverString, a provider of NLP and ML-driven company data for sale and marketing teams. These acquisitions are likely to drive long-term growth for the company and expand its enterprise clientele.

Zacks Rank and Key Picks

Currently, ZoomInfo carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader technology sector include Cadence Design Systems CDNS, Microsoft MSFT and NVIDIA NVDA, all carrying a Zacks Rank #2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The long-term earnings growth rate for Cadence, Microsoft and NVIDIA is currently pegged at 15.4%, 12.5%, and 18.3%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Microsoft Corporation (MSFT) : Free Stock Analysis Report
 
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
 
Cadence Design Systems, Inc. (CDNS) : Free Stock Analysis Report
 
ZoomInfo Technologies Inc. (ZI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research